Lymphoma
2,052
187
263
1,176
Key Insights
Highlights
Success Rate
83% trial completion
Published Results
421 trials with published results (21%)
Research Maturity
1176 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
11.8%
243 terminated out of 2052 trials
82.9%
-3.7% vs benchmark
9%
176 trials in Phase 3/4
36%
421 of 1176 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1176 completed trials
Clinical Trials (2052)
Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Flow on FNA/Core Project- Faster Diagnosis for Lymphoma: Utilising Flow Cytometry on FNA Samples of Lymph Nodes to Diagnose Lymphoma in Hours, Not Days.
Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.
BV-CHEP Chemotherapy for Adult T-cell Leukemia or Lymphoma
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma
Agriculture Health Study
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
Nivolumab in Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders and EBV-Positive Non-HodgkinLymphomas
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant
Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Cellular Therapy
Digitalized Exercise Fit Tool Intervention for Adolescents With Blood Cancer
The CARDIOPROTECT Trial
Vaccine Responses in Patients With B Cell Malignancies
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive Chemotherapy
A Phase 2 Trial of Mosunetuzumab and Zanubrutinib for Patients With Relapsed/Refractory Marginal Zone Lymphoma
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and Lymphoma